High-Intensity Statin Therapy with Simvastatin and Rosuvastatin

Statin Intensity Comparison

• The American College of Cardiology defines high-intensity statins as those that lower LDL-C by ≥50% from baseline, and both simvastatin 80 mg and rosuvastatin 20 mg are classified as high-intensity statins 1, 2
• Simvastatin 80 mg is categorized as a high-intensity statin, reducing LDL-C by approximately 50% 2, 3
• Rosuvastatin 20 mg is also categorized as a high-intensity statin, reducing LDL-C by approximately 50-55% 1, 4

Clinical Considerations

Safety Considerations

• The FDA no longer recommends initiating or titrating to simvastatin 80 mg due to increased risk of myopathy and rhabdomyolysis, making rosuvastatin 20 mg a safer choice 1, 4
• Rosuvastatin 20 mg has a better safety profile than simvastatin 80 mg while providing similar or greater LDL-C reduction 1, 4

Practical Application

• For patients requiring high-intensity statin therapy, rosuvastatin 20 mg is the preferred option compared to simvastatin 80 mg due to safety concerns with the latter 1, 4
• If a patient is currently on simvastatin 80 mg, consider switching to rosuvastatin 20 mg for similar efficacy with improved safety profile 1

Common Pitfalls to Avoid

• The American College of Cardiology recommends never initiating simvastatin 80 mg in new patients due to FDA warnings about myopathy risk 1, 4
• Avoid overlooking potential drug interactions, particularly with amiodarone, ranolazine, and other medications that may increase statin-associated adverse effects 5